If the inline PDF is not rendering correctly, you can download the PDF file here.

A

Abacavir (ABC), 62

Abbreviated new drug applications (ANDAs), 121

Abbreviations

extended-release dosage forms, 135–136

in medication errors, 104

pharmacy, 150

Abelcet, 63

Abilify, 41, 42

Abilify Maintena, 42

Abraxane, 67

Absorption, 140

Acarbose, 53

Accolate, 47

Accounting basics, 186

Account number, 151

Accrediting and regulatory agencies, 159

Accupril, 45

Accuretic, 45

Accutane, 123, 157

ACE inhibitors, 45, 70

Aceon, 45

Acetaminophen with codeine, 51, 119

Acetaminophen with hydrocodone, 51

Acetaminophen with oxycodone, 51

Acetaminophen with tramadol, 51

Aciphex, 54

Aclidinium, 47

Acquisition cost, 186

Actiq, 51

Activase, 65

Active metabolite, 141

Actonel, 49

Actonel and calcium, 49

Actoplus Met, 53

Actos, 52

Adalat CC, 46

Adalimumab, 55, 58

Adasuve, 42

Adderall, 43, 119

Adderall XR, 43

Addition, 10

Additives, 75

ADHD, drugs for, 42–43

ADME

absorption, 140

distribution, 140–141

excretion, 141–142

factors affecting, 142

metabolism, 141

AdmeLOG, 52

Administration of drugs. see Routes of administration

Admission/discharge/transfer (ADT), 192

Admixture programs, 84–85

end-product evaluation, 85

policies and procedures, 84–85

process validation, 85

quality assurance programs, 85

training, 85

Admixtures, categories of, 75–76

Adriamycin, 66

Adrucil, 66

Advair, 47

Advair HFA, 47

Advicor, 43

Advil, 50

Aerosols, 136

Aerospan, 48

Afrezza, 52

Afrin, 49

Agonists, 143

AIDS drug assistance programs, 187

Air embolus in IV therapy, 76

Alavert, 48

Albiglutide, 53

Albuterol, 47

Alcoholic solutions, 133

Aldactazide, 44

Aldactone, 44

Aldesleukin, 67

Alemtuzumab, 38, 67

Alendronate, 49

Alendronate/cholecalciferol, 49

Alert fatigue, 192

Aleve, 50

Alfenta, 51

Alfentanil, 51

Alfuzosin, 60

Alimta, 66

Alirocumab, 43

Aliskiren/HCTZ, 44

Alkeran, 66

Alkylating agents, 66

Allegra, 48

Allergic reaction in IV therapy, 76

Alligation method, 22–23

Almotriptan, 38

Alogliptin, 53

Alogliptin/pioglitazone, 53

Alogliption/metformin, 53

Alosetron, 123, 157

Aloxi, 55

Alpha1-adrenergic antagonists (α-blockers), 70

Alpha1 adrenergic inhibitors (α-blockers), 60

Alphagan P, 57

Alpha-glucosidase inhibitors, 53

α-blockers, 70

Alprazolam, 41

Alprostadil, 60

Altace, 45

Altafrin, 57

Alteplase, 65

Altoprev, 43

Alvesco, 48

Alzheimer disease agents, 37

Amantadine, 37

Amaryl, 52

Ambien, 42

Ambien CR, 42

AmBisome, 63

Ambulatory care pharmacists, 159

Amerge, 38

American Society of Hospital Pharmacists (ASHP), 102, 107

Amifostine, 67

Aminophylline, 47

Aminosalicylates, 55, 70

Amitriptyline, 39, 40

Amlodarone, 46

Amlodipine, 46

Amlodipine/atorvastatin, 43, 46

Amlodipine/benazepril, 46

Amlodipine/olmesartan, 45

Amlodipine/olmesartan/HCTZ, 46

Amlodipine/valsartan, 45

Amlodipine/valsartan/HCTZ, 45

Amnesteem, 123, 157

Amoxicillin, 62

Amoxicillin/clavulanate, 62

Amphetamine, 42

Amphotericin B, 63

Ampicillin, 62

Ampules, 81

Amylin analog, 53

Anabolic Steroid Control Act, 117

Anafranil, 40

Anaprox DS, 50

Anastrozole, 66

Ancef, 60

Androgen hormone inhibitors, 60

Angiomax, 65

Angiotensin II receptor blockers (ARBs), 45

Anidulafungin, 63

Antiepileptics, 36–37

Anoro Ellipta, 47

Antagonists, 143

Antara, 43

Anteroom, 78

Angiotensin II receptor antagonists (ARB), 70

Anthracyclines, 70

Antiallergy agents, ophthalmic, 57

Antiarrhythmic agents, 46

Antibiotic agents, 57, 66

Antibiotic/steroid combinations, ophthalmic agents, 57

Anticholinergics, 37, 47

Anticoagulants, 65

Antidepressants, 40–41

MAOIs, 40

for neuropathic pain, 39

SNRIs, 40

SSRIs, 40

tricyclic, 40

Antidiabetic agents (hypoglycemics), 52–53

Antidiarrheal medications containing opiate, 119

Antiemetic agents, 55

Antiepileptics, 39, 41

Antifungal agents, 63, 70

Antihistamines, 48

Anti-infectives, 60–64

antifungals, 63

antiviral agents, 62–63

cephalosporins, 60–61

fluoroquinolones, 61

macrolides, 61

penicillins, 62

vaccines, 64

Antimetabolites, 66

Antineoplastic drugs, 83, 176

Antipsychotics, 41–42

Antithrombotics, 104

Antitussives, 49

Antivert, 55

Antiviral agents, 57, 62–63, 70

Anxiety disorders, drugs for, 41

Anzemet, 55

Apidra, 52

Apixaban, 65

Apokyn, 37

Apomorphine, 37

Apothecary system, 15–17

avoirdupois system, 15

equivalencies between systems, 15–16

household system, 15

temperature conversion, 16

time conversion, 17

Apraclonidine, 57

Aprepitant, 55

Apriso, 55

Aptiom, 36

Aptivus, 63

Aqueous solutions, 132–133

Arabic numbers, 9

ARB (angiotensin II receptor antagonists), 70

Arbidopa/levodopa/entacapone, 37

Arcapta, 47

Arformoterol, 47

Argatroban, 65

Aricept, 37

Arimidex, 66

Aripiprazole, 41, 42

Arixtra, 65

Armour Thyroid, 54

Arnuity Ellipta, 48

Aromasin, 66

Aromatase inhibitors, 66, 70

Artane, 37

Arthritis, biologic agents to treat, 58

Arthrotec, 50

Asacol HD, 55

ASAP, 151

Ascorbic acid, 69

Aseptic techniques, in IV therapy, 76

ASHP Technical Assistance Bulletin on Single Unit and Unit Dose Packages of Drugs, 92

Asmanex, 48

Asmanex HFA, 48

Asparaginase, 68

Aspart, 52

Aspart protamine and aspart, 52

Astelin, 48

Asthma, agents to treat, 47

Atacand, 45

Atacand HCT, 45

Atazanavir (ATV), 62

Atelvia, 49

Atenolol, 44, 46

Atenolol/chlorthalidone, 44

Ativan, 36, 41, 119

Atomoxetine, 43

Atorvastatin, 43

Atrovent HFA, 47

Atypical antipsychotics, 41, 42

Aubagio, 38

Augmentin, 62

Automated dispensing cabinets (ADCs), 103, 192, 193

Automated medication dispensing devices, 158

Automated repackaging systems, 90–91

Automated system for inventory management, 178–179

Automated TPN compounding, 82–83

Automation, 107

Avalide, 45

Avandia, 52

Avapro, 45

Avastin, 67

Avelox, 61

Average manufacturer price (AMP), 186–187

Average sales price (ASP), 186–187

Average wholesale price (AWP), 186

Avinza, 51

Avodart, 60

Avoirdupois system, 15

Avonex, 38

Axert, 38

Azasan, 55

AzaSite, 57

Azathioprine, 55

Azelastine, 48, 57

Azelastine/fluticasone, 49

Azilect, 37

Azilsartan, 45

Azithromycin, 57, 61

Azole antifungals, 63

Azopt, 57

Azor, 45

Azulfidine, 55

Azurette, 59

B

Baclofen, 39, 50

Balsalazide, 55

Barbiturates, 70

Barcode-assisted medication administration (BCMA), 102, 158, 175, 192–193

Basaglar, 52

Basal (long-acting) insulins, 52

Batch repacking, 90

Beclomethasone, 48, 49

Beconase AQ, 49

Benadryl, 48

Benazepril, 45

Benazepril/HCTZ, 45

Benicar, 45

Benicar HCT, 45

Benign prostatic hypertrophy (BPH), agents used to treat, 60

Benzodiazepines, 41, 42, 70

Benztropine, 37

Besifloxacin, 57

Besivance, 57

Beta blockers, 44, 57, 70

Betagan, 57

Betapace, 44, 46

Betaseron, 38

Betaxolol, 57

β-adrenergic antagonists (beta-blockers), 70

Betoptic-S, 57

Betrixaban, 65

Bevacizumab, 67

Bevel, needle, 80

Bevyxxa, 65

Bexarotene, 68

Beyond-use date (BUD), 81–82, 86, 92

Biaxin, 61

Bicillin, 62

Bicillin LA, 62

BiCNU, 66

Biguanides, 52

Bile acid sequestrants, 43

Billing/reimbursement and information systems, 186–203

accounting basics, 186

claims processing, 189–190

computer skills, basic, 191

downtime planning, 196

payment for drugs and dispensing services, 187–189

pharmacy informatics, 191–192, 196, 197

prescription processing, 190–191

reimbursement basics, 186–187

retail practice, 194–195

self-assessment answers, 202

self-assessment questions, 198–202

terminology, key, 191–193

Bimatoprost, 57

Bioavailability, 140

Biological product substitution, 121

Biological safety cabinets (BSCs), 77, 83

Biologic response modifiers, 67

Biopharmaceutics, 140

Bipolar disease, drugs for, 41

Bisacodyl, 56

Bisoprolol, 44

Bisoprolol/HCTZ, 44

Bisphosphonates, 49

Bitter orange, 71

Bivalirudin, 65

Bleomycin, 66

Bleph-10, 57

Blister packages, 90

Body surface area (BSA), 17–18

Body systems, drugs that effect, 36–58

cardiovascular system, 43–46

endocrine system, 52–54

gastrointestinal system, 54–56

musculoskeletal system, 49–51

nervous system, 36–43

other body systems, 57–58

respiratory system, 47–49

urinary system, 56

Bolus dose, 139

Bone supplements, 71

Bonine, 55

Boniva, 49

Borrowing pharmaceuticals, 174

Bortezomib, 68

Bowel evacuants, 56

Brand name drugs, 121–122, 150

Bravelle, 59

Breo Ellipta, 47

Brevibloc, 46

Brimonidine, 57

Brimonidine/Timolol, 57

Brinzolamide, 57

Brinzolamide/Brimonidine, 57

Brivaracetam, 36

Briviact, 36

Broad-spectrum penicillins, 62

Brodalumab, 58

Bromocriptine, 37

Brovana, 47

Bubble packs, 90

Buccal route of administration, 137, 138

Buccal tablets and films, 134, 137

Budesonide, 48, 49

Buffer room, 78

Bulk-forming laxatives, 56

Bumetanide, 44

Bumex, 44

Buprenex, 51

Buprenorphine, 51

Buprenorphine with naloxone, 51

Bupropion, 39, 40

BuSpar, 41

Buspirone, 41

Busulfan, 66

Busulfex, 66

Butalbital, acetaminophen, caffeine, 39

Butalbital, acetaminophen, caffeine, codeine, 39

Butalbital, aspirin, caffeine, 39

Butalbital, aspirin, caffeine, codeine, 39

Butalbital and acetaminophen, 39

Butalbital-containing products, 39

Butorphanol, 51

Bydureon, 53

Byetta, 53

Bystolic, 44

C

Cabazitaxel, 67

Caduet, 43, 46

Cafergot, 39

Caffeine, 71

Calan, 46

Calcitonin, 49

Calcium, 69, 71

Calcium carbonate, 49

Calcium carbonate + vitamin D, 49

Calcium channel blockers, 46, 70

Calcium citrate, 49

Calcium supplements, 49

Calculations

chemotherapy, 23–24

dosage, 17–19

errors in, 103

patient-specific, 17

practice, 25–31

practice answers, 31–34

Caltrate, 49

Caltrate +D, 49

Campath, 67

Camptosar, 68

Canagliflozin, 53

Canagliflozin/metformin, 53

Canasa, 55

Cancidas, 63

Candesartan, 45

Candesartan/HCTZ, 45

Capecitabine, 66

Caplets, 134, 135

Capsaicin, 39

Capsules, 89, 134, 135

Captopril, 45

Carbamazepine, 36, 39, 41

Carbidopa/levodopa, 37

Carbonic anhydrase inhibitors, 57, 70

Carboplatin, 67

Cardene, 46

Cardiovascular system, drugs that effect, 43–46

ACE inhibitors and ARBs, 45

antiarrhythmic agents, 46

beta blockers, 44

calcium channel blockers, 46

cholesterol-lowering agents, 43

diuretics, 44

Cardizem, 46

Cardura, 60

Cardura XL, 60

Carisoprodol, 50

Carmustine, 66

Carrying costs, 177

Carvedilol, 44

Cash price, 187

Caspofungin, 63

Cathflo, 65

Caverject, 60

Cedax, 61

Cefaclor, 60

Cefadroxil, 60

Cefazolin, 60

Cefdinir, 61

Cefepime, 61

Cefixime, 61

Cefotaxime, 61

Cefotetan, 61

Cefoxitin, 61

Cefpodoxime, 61

Cefprozil, 61

Ceftaroline, 61

Ceftazidime, 61

Ceftibuten, 61

Ceftin, 61

Ceftriaxone, 61

Cefuroxime, 61

Celebrex, 50

Celecoxib, 50

Celexa, 40

Centers for Medicare & Medicaid Services (CMS), 77, 125, 171, 189

Centralized pharmacy services, 157–158

Cephalexin, 60

Cephalosporins, 60–61, 70

Cerebyx, 36

Certified nursing assistants (CNAs), 160

Certolizumab, 55, 58

Cervical cancer, 64

Cetirizine, 48

Cetrorelix, 59

Cetrotide, 59

Cetuximab, 67

Chain pharmacies, 159

Chantix, 124

Checkpoints, 93

Chemotherapy calculations, 23–24

Chemotherapy drugs, 66–68, 104, 105

Chewable tablets, 135

Chicken pox, 64

Child-resistant packaging, 122

Chlorambucil, 66

Chlordiazepoxide, 41

Chloride, 69

Chlorothiazide, 44

Chlorpheniramine, 48

Chlorpromazine, 42

Chlor-Trimeton, 48

Chlorzoxazone, 50

Cholesterol-lowering agents, 43

Cholestyramine, 43

Cholinesterase inhibitors, 37

Chondroitin, 71

Chorionic gonadotropin, 59

Cialis, 60

Ciclesonide, 48, 49

Ciloxan, 57

Cimetidine, 54

Cimzia, 55, 58

Cipro, 61

Ciprofloxacin, 57, 61

Cisplatin, 67

Citalopram, 40

Citracal, 49

Citroma, 56

Citrucel, 56

Claforan, 61

Claims processing, 189–190

Claravis, 123, 157

Clarinex, 48

Clarithromycin, 61

Claritin, 48

Cleaning, 78, 84

Clean room, 78

Clear Eyes, 57

Clemastine, 48

Clevidipine, 46

Cleviprex, 46

Clinical decision support (CDS) system, 192

Clinic pharmacies, 159

Clinics, claims processing in, 190

Clobazam, 36

Clobetasol, 58

Clobex, 58

Clodan, 58

Clomiphene, 59

Clomipramine, 40

Clonazepam, 36, 41

Closed-system containers, 81

Cloxacillin, 62

Clozapine, 42, 123, 157

Clozaril, 42, 123, 157

Codeine, 51, 119

Cogentin, 37

Colace, 56

Colazal, 55

Colesevelam, 43

Colestid, 43

Colestipol, 43

Color coding, 105

Combat Methamphetamine Epidemic Act (CMEA), 117, 120

Combigan, 57

Combivent Respimat, 47

Community pharmacies, 159–160, 190

Competency. see Education and training

Complementary and alternative medicine (CAM), 71

Compliance errors, 102

Compounded preparations, 88–89

capsules, 89

handling considerations, 176–177

lozenges and troches, 89

solutions and suspensions, 88–89

suppositories, 89

Compounded sterile preparations (CSPs)

beyond-use dating, 81–82

defined, 77

gowning, 78–79

intravenous workflow software, 193

primary engineering control, 77

Compounding

errors, 106

manufacturers, 180

manufacturing differentiated from, 85

nonsterile, 88–93

pharmacy, 75, 77

prescription, 85–88

self-assessment answers, 99

self-assessment questions, 94–98

sterile, 75–88

Compounding aseptic isolators (CAIs), 83

Compounding Quality Act, 180

Compounding supplies, 79–82

beyond-use dating, 81–82

drug additive containers, 80–81

needles, 80

syringes, 79–80

Compressed tablets, 134

Compro, 55

Computerization

inventory management system, 178–179

medication errors, 107

testing, 5

Computerized physician order entry (CPOE), 192

Computer order entry errors, 102

Computer skills, basic, 191

Comtan, 37

COMT inhibitors, 37

Concentration

expressed as percentages, 12, 19, 20

expressed as ratio strength, 20–21

Concerta, 43, 119

Consumer medicine information (CMI), 122

Consumer payments (self-pay), 187

Containers and repackaging materials, 90

Continuous infusion, 139

Continuous medications or drips, 76

Continuous quality improvement (CQI), 125, 126

Contraceptives, 59

Controlled substances, 118–120

defined, 118

dispensing, 119–120

ephedrine or pseudoephedrine, restrictions on sales of, 120

labeling of, 119

product handling considerations, 175–176

schedules for, 118–119

state prescription drug monitoring programs, 120

Controlled Substances Act, 118

Controlled Substances Ordering System (CSOS), 175

Conventional amphotericin B, 63

Conventional antipsychotics, 42

Conversion factor, 15

Conversions

temperature, 16

time, 17

Copaxone, 38

Copayment, 186

COPD, agents to treat, 47

Cordarone, 46

Coreg, 44

Coreg CR, 44

Corgard, 44

Coring, 81

Correctol, 56

Cortaid, 58

Corticosteroids, 58, 70

Cortizone-10, 58

Corvert, 46

Cosentyx, 58

Cosmegen, 66

Cosopt, 57

Cough and cold agents, 49, 119

Coumadin, 65

Council for Medication Error reporting and Prevention (NCC MERP), 101, 104

Counterfeit pharmaceuticals, 179

Course dose versus daily dose, 105

Covered entities, 180, 187

COX-2 inhibitors, 50

Cozaar, 45

Creams, 135

Crestor, 43

Crinone, 59

Critical area, 79

Crixivan, 63

Crolom, 57

Cromolyn, 57

Current Procedural Terminology (CPT) codes, 190

Cyanocobalamine, 69

Cyclobenzaprine, 50

Cyclophosphamide, 66

Cyclosporine, 57

Cymbalta, 39, 40

CYP enzymes, 142

Cyramza, 67

Cytarabine, 66

Cytochrome P450 (CYP) system, 141

Cytomel, 54

Cytoprotective agents, 67

Cytosar, 66

Cytoxan, 66

D

Dabigatran, 65

Dabrafenib, 68

Dacarbazine, 66

Daclizumab, 38

Dactinomycin, 66

Dalmane, 42

Dalteparin, 65

Dantrium, 50

Dantrolene, 50

Dapagliflozin, 53

Dapagliflozin/metformin, 53

Darifenacin, 56

Darunavir (DRV), 62

Dasatinib, 68

Daunorubicin, 66

Daypro, 50

Day’s supply of medication, calculating, 18–19

Daytrana, 43

Decentralized pharmacy services, 157–158

Decimal numbers

converting fractions to, 10

converting mixed numbers to, 11

converting to mixed numbers or fractions, 11

rules governing use of, 11

Decongestants, 49

Deductible, 188

Definition of terms, 4

Degludec, 52

Degludec and liraglutide, 52

Delavirdine (DLV), 62

Delsym, 49

Demadex, 44

Demerol, 51, 119

Denosumab, 49

Depacon, 36

Depakene, 36, 39

Depakote, 36, 39, 41

Depakote ER, 36

Department of Defense, 189

Department of Veterans Affairs (VA), 189

Depocyt, 66

Depo-Provera, 59

Depression, CAM supplements for, 71

Desipramine, 40

Desirudin, 65

Desloratadine, 48

Desonide, 58

DesOwen, 58

Desoximetasone, 58

Desvenlafaxine, 40

Desyrel, 40

Detemir, 52

Deteriorated drug errors, 102

Deteriorated medications, 106

Det Norske Veritas Healthcare, Inc (DNV), 77, 159

Detrol, 56

Detrol LA, 56

Dexedrine, 42

Dexilant, 54

Dexlansoprazole, 54

Dexmethylphenidate, 42

Dextroamphetamine, 42

Dextromethorphan, 49

Dextrose 5% in normal saline (D5NS), 20

Dextrose 5% in water (D5W), 20

Dextrose 10% in water (D10W), 20

D.H.E., 39, 45

Diagnosis codes, 190

Diagnosis-related groups (DRGs), 188, 190

Diastat, 36

Diazepam, 36, 41, 50, 119

Diclofenac, 50

Diclofenac/misoprostol, 50

Didanosine (ddl), 62

Dietary supplements, 160

Diflucan, 63

Dihydroergotamine, 39

Dihydropyridines, 70

Dilantin, 36

Dilaudid, 51

Diltiazem, 46

Dilutions

alligation method, 22–23

made from stock solutions, 21–22

pediatric formulations, 22

Dimenhydrinate, 55

Dimethyl Fumarate, 38

Diovan, 45

Diovan HCT, 45

Dipeptidyl peptidase-4 (DPP-4) inhibitors, 53, 70

Diphenhydramine, 48

Diphenoxylate/atropine, 119

Direct purchasing, 173–174

Direct thrombin inhibitors, 65

Dirithromycin, 61

Disintegration, 140

Disopyramide, 46

Dispense as Written (DAW), 153

Dispensing fee, 186

Disproportionate share hospitals (DSH), 187

Dissolution, 140

Distractors, eliminating, 3

Distribution, 140–141

Distributor, 174

Ditropan, 56

Ditropan XL, 56

Diuretics, 44

Diuril, 44

Divalproex, valproic acid, 39

Divalproex sodium, 36, 41

Division, 10

Docetaxel, 67

Documentation of medication error, 108

Docusate calcium, 56

Docusate sodium, 56

Dofetilide, 46, 123, 157

Dolasetron, 55

Dolutegravir (DTG), 63

Donepezil, 37

Dopamine agonists, 37

Doral, 42

Dorzolamide, 57

Dorzolamide/Timolol, 57

Dosage calculations, 17–19

based on body surface area, 18

based on weight, 18

basic principle, 17–18

day’s supply, 18–19

24-hour supply, 19

Dose, course versus daily, 105

Downstream contamination, 79

Downtime planning, 196

Doxazosin, 60

Doxepin, 40

Doxorubicin, 66

Dramamine, 55

Drips, 76

Dristan, 49

Dronedarone, 46

Drop, 15

Drug additive containers, 80–81

ampules, 81

vials, 80–81

Drug–allergy interaction, 155

Drug clearance, 141

Drug concentration, 105

Drug-drug interaction, 142, 155

Drug Enforcement Administration (DEA)

Form 41, 181

Form 222, 175

numbers, 19, 118, 153, 154

Drug-food interaction, 142

Drug information questions, 160–163

appropriate for pharmacists, 162–163

classifications of, 162

requests and reference sources, 163

Drug interactions, 142

Drug names, TALL man lettering and, 105

Drug preparation errors, 106

Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman Act), 117

Drug product characteristics, 105

Drug Quality and Security Act (DQSA), 179–180

Drug recalls, 124–126

FDA drug recall classes, 125

FDA’s role in, 124–125

investigational drugs, 125

manufacturer/distributor’s role in, 125

quality assurance mechanisms, 125, 126

Drug-receptor complex, 143

Drug Registration and Listing System (DRLS), 172

Drug Safety Board, 117

Drug shortages, medication errors related to, 102

Drug Supply Chain Security Act (DSCSA), 192

Drug wholesaler, 174

Dry eye agents, 57

DTIC-Dome, 66

Duetact, 53

Dulaglutide, 53

Dulcolax, 56

Dulera, 47

Duloxetine, 39, 40

Duoneb, 47

Durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS), 188

Duragesic, 51

Durham-Humphrey Amendment, 117

Dutasteride, 60

Dutasteride/tamsulosin, 60

Dyazide, 44

Dymista, 49

Dynabac, 61

Dynapen, 62

Dyrenium, 44

E

Echinacea, 71

Echinocandins, 63, 70

Economic models of inventory, 178

Economic order quantity (EOQ), 177, 178

Edarbi, 45

Edecrin, 44

Edex, 60

Edoxaban, 65

Education and training

admixture programs, 85

medication safety, 107

quality control, 92

Edular, 42

Edurant, 62

Efavirenz (EFV), 62

Effervescent tablets, 134

Effexor, 39, 40

Effexor XR, 40

Elavil, 39, 40

Eldepryl, 37

Electrolytes, 21

Electronic eMAR, 153

Electronic infusion devices and smart pumps, 82

Electronic medical (or health) record (EHR), 186, 192

Electronic prescribing (eRx), 194–195

Elestat, 57

Eletriptan, 38

Eligard, 67

Eliquis, 65

Elixirs, 133

Elixophyllin, 47

Elocon, 58

Elspar, 68

Elvitegravir (EVG), 63

Emadine, 57

Emcyt, 66

Emedastine, 57

Emend, 55

Empagliflozin, 53

Empagliflozin/linagliptin, 53

Empagliflozin/metformin, 53

Emsam patch, 37

Emtricitabine (FTC), 62

Emtriva, 62

Enablex, 56

Enalapril, 45

Enalaprilat, 45

Enalapril/HCTZ, 45

Enbrel, 58

Endocrine system, drugs that effect, 52–54

antidiabetic agents (hypoglycemics), 52–53

insulins, 52

thyroid agents, 54

Endometrin, 59

End-product evaluation, 85

End-product testing, 93

Energy supplements, 71

Engineering controls, 77

Enoxaparin, 65

Entacapone, 37

Enteral medications, defined, 75

Enteral route of administration, 137, 138

Entericcoated oral tablets, 134

Entresto, 45

Entyvio, 55

Environmental Protection Agency (EPA), 177, 179

Enzymes, 141

Ephedrine, restrictions on sales of, 120

Epinastine, 57

Epivir, 62

Eplerenone, 44

Eprosartan, 45

Equalactin, 56

Equetro, 41

Equipment maintenance, 92–93

Eraxis, 63

Erbitux, 67

Erectile dysfunction, drugs for, 60

Ergocalciferol, 69

Ergomar, 39

Ergotamine/caffeine, 39

Ergotamine derivatives, 39

Erlotinib, 68

Error reporting, medication, 103

Erythromycin, 57, 61

Escitalopram, 40

Esgic, 39

Eslicarbazepine, 36

Esmolol, 46

Esomeprazole, 54

Essay exams, 1

Essences, 133

Estazolam, 42

Estramustine, 66

Estrogen and progesterone products, 59

Eszopiclone, 42

Etanercept, 58

Ethacrynic acid, 44

Ethyol, 67

Etodolac, 50

Etoposide, 68

Etravirine (ETV), 62

Evekeo, 42

Evista, 49

Evolocumab, 43

Exalgo, 51

Examination preparation

definition of terms, 4

final review, 4

group review, 4

mock exams, 4

for objective exams, 2, 4

personal preparation, 4

question charts, 3–4

time management, 2

work habits, 2–3

Examinations

multiple-choice questions, 2

test anxieties, 7–8

types of, 1

Excretion, 141–142

Exelon, 37

Exemestane, 66

Exempt narcotics/exempt prescription products, 118, 119

Exenatide, 53

Exforge, 45

Exforge HCT, 45

Ex-Lax, 56

Expectorants, 49

Expenses, 186

Expired pharmaceuticals, disposal and return of, 180–181

Express Scripts, 189

Extemporaneous repackaging, 90

Extended-release dosage forms, 135–136

External phase, 133

Extractives, 132, 133

Extracts, 133

Extravasation in IV therapy, 76

Ezetimibe, 43

Ezetimibe/simvastatin, 43

Ezogabine, 36

F

Factive, 61

Factor Xa inhibitors, 65

Failure mode and effects analysis (FMEA), 107

Famotidine, 54

Fareston, 68

Farxiga, 53

Fazaclo, 42, 123, 157

Federal poverty limits (FPLs), 189

Federal qualified health centers (FQHC), 187

Fee for service, 186

Feldene, 50

Felodipine, 46

Femara, 66

Fenofibrate, 43

Fenofibric acid, 43

Fenoglide, 43

Fentanyl, 51, 104

Fentora, 51

Fertility agents, 59

Fesoterodine, 56

Fetzima, 40

Fexofenadine, 48

FiberCon, 56

Fibrates, 43

Fifth-generation agent, cephalosporins, 61

Final review, 4, 7

Financial liquidity, 177

Finasteride, 60

Fingolimod, 38

Fioricet, 39

Fioricet with codeine, 39

Fiorinal, 39

Fiorinal with codeine, 39

First-generation agents, 38, 60

5-HT3 antagonists, 55

5-HT agonists, 70

5 rights of medication administration, 158

5α-reductase inhibitors, 70

Flecainide, 46

Flector, 50

Fleet Mineral Oil Enema, 56

Flomax, 60

Flonase, 49

Flonase Sensimist, 49

Flovent Diskus, 48

Flovent HFA, 48

Flow rate calculations, IV, 24

Floxin, 61

Floxuridine, 66

Fluconazole, 63

Flunisolide, 48, 49

Fluocinonide, 58

Fluoroquinolones, 61

Fluorouracil, 66

Fluoxetine, 39, 40

Fluphenazine, 42

Flurazepam, 42

Flurbiprofen, 50

Fluroquinolones, 70

Fluticasone, 49

Fluticasone Furoate, 48

Fluticasone propionate, 48

Fluvastatin, 43

Fluvoxamine, 40

Focalin, 42

Follistim AQ, 59

Follitropin alfa, 59

Follitropin beta, 59

Fondaparinux, 65

Food, Drug, and Cosmetic (FDC) Act, 116, 117, 180

Food and Drug Administration (FDA), 117, 121, 122, 124–125, 156, 172, 180, 192

Food and Drug Administration Modernization Act, 117

Food and Drugs Act, 117

Formoterol, 47

Formoterol/budesonide, 47

Formoterol/mometasone, 47

Formulary, 150, 155, 187–188

Formulary system, 172–173

Fortamet, 52

Fortaz, 61

Forteo, 49

Fortical, 49

Fosamax, 49

Fosamax + D, 49

Fosamprenavir (FPV), 63

Fosaprepitant, 55

Fosinopril, 45

Fosphenytoin, 36

Fourth-generation agents, 61

Fractions

converting decimal numbers to, 11

converting percentages to, 12

converting to decimal numbers, 10

converting to percentages, 12

Fragmin, 65

Free-flow protection, 82

Frova, 38

Frovatriptan, 38

Furosemide, 44

Fycompa, 36

G

Gabapentin, 36, 39

Gabitril, 36

Galantamine, 37

Ganciclovir, 57

Ganirelix, 59

Gastrointestinal system, drugs that effect, 54–56

antiemetic agents, 55

histamine-2 (H2) antagonists, 54

inflammatory bowel disease, agents to treat, 55

laxatives, 56

proton pump inhibitors, 54

Gatifloxacin, 57

Gauge of needle, 80

Gefitinib, 68

Gels, 133

Gemcitabine, 66

Gemfibrozil, 43

Gemifloxacin, 61

Gemzar, 66

Generic drugs, 121–122, 150

Generic drug substitution, 121

Generlac, 56

Genital warts, 64

Gentak, 57

Gentamicin, 57

Geodon, 41, 42

Giazo, 55

Gilenya, 38

Ginseng, 71

Glargine, 52

Glargine and lixisenatide, 52

Glatiramer acetate, 38

Gleastine, 66

Gleevec, 68

Glimepiride, 52

Glipizide, 52

Glipizide/metformin, 53

Glitazones (thiazolidinediones), 52

Glove boxes, 83

Glucophage, 52

Glucosamine, 71

Glucotrol, 52

Glucovance, 53

Glulisine, 52

Glumetza, 52

Glyburide, 52

Glyburide/metformin, 53

Glycerin, 56

Glynase, 52

Glyset, 53

Glyxambi, 53

Golimumab, 55, 58

Gonal-F, 59

Good Manufacturing Practice regulations, 180

Gowning, 78–79

Grain, 15

Gram (g), 14–15

Granisetron, 55

Granules, 136

Greek prefixes, 14

Group purchasing organization (GPO), 173

Group review, 4

Guaifenesin, 49

Guselkumab, 58

H

Halcion, 42

Haldol, 42

Half-life, 142

Half normal saline (1/2 NS), 20

Haloperidol, 42

Handwriting, illegible, 105

Hard gelatin capsules, 135

Hazardous drugs (HDs), handling considerations, 176

Hazardous sterile compounding, 83–84

biological safety cabinets, 83

categories of, 83

cleaning requirements of USP Chapter <800>, 84

labeling, storage, and transport, 84

protective apparel, 84

waste disposal and spill cleanup, 84

Headaches, drugs for, 38–39

Healthcare Common Procedure Coding System (HCPCS), 190

Healthcare Facilities Accreditation Program (HFAP), 159

Health Care Financing Administration (HCFA), 125

Health Insurance Claim Number (HICN), 190

Health Insurance Portability and Accountability Act (HIPAA), 123

Health maintenance organization (HMO), 159

Health Resources and Services Administration (HRSA), 180, 187

Heavy metal compounds (platinums), 67

Hematologic agents, 65

Heparin, 65, 104

Hepatitis A vaccine, 64

Hepatitis B vaccine, 64

Herbals and other dietary supplements, 71

Herceptin, 68

Heroin, 119

Herpes Zoster vaccine, 64

High alert medications, 104, 105

High efficiency particulate air (HEPA) filters, 77–79, 83

High potency corticosteroids, 58

High-risk compounds, 82

Histamine-2 (H2) antagonists, 54

HIV agents, 62–63

HMG CoA inhibitors, 43, 70

Home care, 160

Horizant, 39

Horizontal LAFW, 77

Hormones, as chemotherapy agent, 67

Hospital

receiving and processing medication orders in, 150–153

receiving and processing prescription drugs in, 153

Household system, 15–16

H2 receptor antagonists (H2-blockers), 70

Hub, 80

HumaLOG, 52

HumaLOG 50/50, 52

HumaLOG 75/25, 52

HumaLOG Jr, 52

HumaLOG U 200, 52

Human factors in medication errors, 106

Human Papillomavirus vaccine, 64

Humira, 55, 58

HumuLIN 70/30, 52

HumuLIN N, 52

HumuLIN R, 52

HumuLIN R U-500, 52

Hycamtin, 68

Hycet, 51

Hydroalcoholic solutions, 133

Hydrochlorothiazide, 44

Hydrocodone bitartrate, 51

Hydrocodone with acetaminophen, 119

Hydrocortisone, 58

Hydromorphone, 51, 104

Hydroxyprogesterone caproate, 59

Hyperalimentation. see Total parenteral nutrition (TPN)

Hyperosmotic laxatives, 56

Hyperthyroidism, agents to treat, 54

Hypnotic medications, 42, 119

Hypoglycemic agents, 52–53, 104

Hypothyroidism, agents to treat, 54

Hyzaar, 45

I

Ibandronate, 49

Ibritumomab, 67

Ibuprofen, 50

Ibuprofen with hydrocodone, 51

Ibutilide, 46

Idamycin, 66

Idarubicin, 66

Ideal body weight (IBW), 17

Idelalisib, 68

Imatinib, 68

Imipramine, 40

Imitrex, 38

Immediate-use compounds, 81

Immune system modulators, 71

Immunizations, 160

Immunosuppressive agents, 55

Implants, 137

Improper dose error, 102

Imuran, 55

Inactivated vaccines, 64

Inactive metabolite, 141

Incompatibilities in IV therapy, 76

Incretin mimetics, 53

Incruse Ellipta, 47

Indacaterol, 47

Independent pharmacies, 159

Inderal, 46

Inderal LA, 44

Indian Health Service (IHS), 189

Indinavir (IDV), 63

Indocin, 50

Indomethacin, 50

Infections, in IV therapy, 76

Inflammatory bowel disease, agents to treat, 55

Infliximab, 55, 58

Influenza vaccine, 64, 160

Ingredient cost, 186

Inhalants, 136

Inhalation route of medication administration, 138, 139

Inhaled corticosteroids, 48

Inpatient pharmacy services, 157–158

Inpatient setting, claims processing in, 190

Inspra, 44

Institute for Safe Medication Practices (ISMPs), 104, 107

Institutional patient assistance programs (IPAPs), 187

Institutional pharmacy, 158

Insulin combinations, 52

Insulins, 52, 104

Insulin U-500, 104

Integrase inhibitors, 63

Integration, 192

Intelence, 62

Interferon beta-1a, 38

Interferon beta-1 b, 38

Intermediate-acting insulins, 52

Intermezzo, 42

Intermittent medications, 75–76

Internal phase, 133

International Classification of Diseases, 10th Revision (ICD-10), 190

International Organization for Standardization (ISO) Class 5 environment, 77

Intradermal (ID) route of medication administration, 139

Intramuscular (IM) route of medication administration, 139

Intravenous (IV) therapy

administration, 75–76, 139

admixture programs, 84–85

aseptic techniques, 76

electronic infusion devices and smart pumps, 82

flow rate calculations, 24

gowning, 78–79

labeling, 82

regulations, 76–77

risks of, 76

standard solutions, 20

total parenteral nutrition, 82–83

workflow software, 193

Invega, 42

Invega Sustenna, 42

Invega Trinza, 42

Inventory turnover, 177

Investigational drugs, 125, 157, 176

Invirase, 63

Invokamet, 53

Invokana, 53

Iodides, 54

Iodine, 69

Iopidine, 57

Ipratropium, 47

Ipratropium/albuterol, 47

Iprivask, 65

Irbesartan, 45

Irbesartan/HCTZ, 45

Iressa, 68

Irinotectan, 68

Iron, 69

Isentress, 63

Isocarboxazid, 40

Isopropyl alcohol (IPA), 78, 84

Isopto Carpine, 57

Isotretinoin, 123, 157

Isradipine, 46

Itraconazole, 63

IV piggy backs, 75–76

IV push, 139

IV push medications, 75

Ixekizumab, 58

J

Jakafi, 68

Jalyn, 60

Jantoven, 65

Janumet, 53

Januvia, 53

Jardiance, 53

Jellies, 133

Jentadueto, 53

Jevtana, 67

Joint Commission (TJC), 15, 77, 107, 125, 159, 172

Joint supplements, 71

Just-in-time inventory management, 175, 177, 178

Just-in-time packaging, 90

K

Kadian, 51

Kazano, 53

Kefauver-Harris Drug Amendments, 117

Keflex, 60

Kefzol, 60

Kenalog, 58

Keppra, 36

Ketoconazole, 63

Ketoprofen, 50

Ketorolac, 50

Ketotifen, 57

Kinase inhibitors, 68

Klonopin, 36, 41

Known ratio, 13–14

Kombiglyze XR, 53

Kondremul, 56

Konsyl, 56

L

Labeling

controlled substances, 119

hazardous sterile compounding, 84

IV therapy, 82

medication errors, 105, 106

misleading labels, 175

new labeling requirements, 117

over-the-counter drugs, 122

policies and procedures, 106

prescription drugs, 121–122, 155–156

repackaging, 92

USP-NF Chapter <795>, 87

Labetalol, 44

Lacosamide, 36

Lactulose, 56

Lamictal, 36, 39, 41

Lamictal XR, 36

Laminar airflow hood (LAH), 80

Laminar airflow workstations (LAFWs), 77

Lamivudine (3TC), 62

Lamotrigine, 36, 39, 41

Lansoprazole, 54

Lantus, 52

Lapatinib, 68

Lasix, 44

Latanoprost, 57

Latin prefixes, 14

Laxatives, 56

Lazanda, 51

Legend drug, 150. see also Prescription drugs

Lemtrada, 38, 67

Length, 14

Length, needle, 80

Lescol, 43

Lescol XL, 43

Letrozole, 66

Letters as part of medication names, 105

Leucovorin, 67

Leukeran, 66

Leukotriene modifiers, 47, 70

Leuprolide, 67

Levalbuterol, 47

Levaquin, 61

Levemir, 52

Levetiracetam, 36

Levitra, 60

Levobunolol, 57

Levocetirizine, 48

Levofloxacin, 57, 61

Levomilnacipran, 40

Levonorgestrel, 59

Levorphanol, 51

Levothroid, 54

Levothyroxine, 54

Levoxyl, 54

Lexapro, 40

Lexiva, 63

Lialda, 55

Librium, 41

Lidocaine, 39, 46

Lidoderm, 39

Limited distribution drugs (LDDs), 123–124

Linagliptin, 53

Linagliptin/metformin, 53

Liniments, 136–137

Lioresal, 50

Liothyronine, 54

Liotrix, 54

Lipid complex, 63

Lipitor, 43

Lipofen, 43

Liposomal, 63

Liquid medication dosage forms, 132–133

advantages/disadvantages of, 132

extractives, 132, 133

solutions, 132–133

suspensions, 132, 133

Liraglutide, 53

Lisdexamfetamine, 42

Lisinopril, 45

Lisinopril/HCTZ, 45

Lispro, 52

Lispro protamine and lispro, 52

Liter (L), metric prefixes for, 14

Lithium carbonate, 41

Lithobid, 41

Livalo, 43

Live/attenuated vaccines, 64

Loading dose, 141

Local anesthetics, 70

Lofibra, 43

Lomotil, 119

Lomustine, 66

Long-acting bronchodilators (LABAs), 47

Long-acting insulin and GLP-1 combinations, 52

Long-acting (basal) insulins, 52

Look-alike/sound-alike (LASA) products, 175

Loop diuretics, 44, 70

Lopid, 43

Lopressor, 44, 46

Lopressor HCT, 44

Loratadine, 48

Lorazepam, 36, 41, 119

Lorcet, 51

Lortab, 51

Losartan, 45

Losartan/HCTZ, 45

Lotensin, 45

Lotensin HCT, 45

Lotions, 133

Lotrel, 46

Lotronex, 123

Lovastatin, 43

Lovaza, 43

Lovenox, 65

Low-molecular-weight heparins, 65

Low potency corticosteroids, 58

Low-risk compounds, 81–82

Loxapine, 42

Lozenges, 89, 134, 135

Lubricant laxatives, 56

Lugol’s solution, 54

Lumigan, 57

Lunesta, 42

Lupron, 67

Lupron Depot, 67

Lyrica, 36, 39

M

Macrolides, 61, 70

Magmas, 133

Magnesium, 69

Magnesium citrate, 56

Magnesium hydroxide, 56

Mail-order pharmacies, 159–160

Makena, 59

Managed care insurance, 187

Managed care pharmacies, 159

Manual blister repackaging systems, 90

Manual for Pharmacy Technicians, 5th Edition, 9, 19, 35, 150

Manual pouch repackaging systems, 90

Manual repackaging systems

for oral liquids, 91

for oral solids, 90

MAO-B inhibitors, 37

Margin, 186

Marijuana, 119

Marplan, 40

Mass, 16

Master formulation record, 87

Matching funds, 189

Material Safety Data Sheet (MSDS), 87

Mathematical functions

addition, 10

converting decimal numbers to mixed numbers or fractions, 11

converting fractions to decimal numbers, 10

converting mixed numbers to decimal numbers, 11

division, 10

multiplication, 10

percentages, 12

proportions, 12–14

ratios, 12–14

subtraction, 10

Matulane, 66

Mavik, 45

Maxalt, 38

Maximum allowable cost (MAC), 187

Maxipime, 61

Maxitrol, 57

Maxzide, 44

Measles, mumps, rubella vaccine, 64

Measures, 14–15

Mechlorethamine, 66

Meclizine, 55

Medicaid, 189

Medicare, 188–189, 190

Medicare Advantage Plan, 188–189

Medicare Advantage Prescription Drug plans (MAPDs), 189

Medicare Prescription Drug, Improvement, and Modernization Act, 117, 189

Medication administration record (MAR), 153

Medication dosage forms, 132–137

liquid medication dosage forms, 132–133

self-assessment answers, 147

self-assessment questions, 144–146

semisolid medication dosage forms, 135–137

solid medication dosage forms, 134–135

Medication errors. see Medication safety abbreviations, 104

ASHP guidelines on preventing, 102

automated dispensing cabinets, 103

barcode technology, 102

calculation errors, 103

causes of, 103–106

compounding/drug preparation errors, 106

computer order entry errors, 102

deficiencies in medication-use systems, 106

defined, 101

drug product characteristics, 105

factors contributing to, 103

high-alert medications, 104, 105

impact of, 103

implementing change, 108

prescribing concerns, 105

prevention strategies, 107

procedures for, 108

related to drug shortages, 102

reporting, 103

transitions of care errors, 103

types of, 102–103

work environment and human factors, 106

Medication Guides, 122, 123, 124, 157

Medication management, 158

Medication order

authenticity, assessing, 154–156

defined, 150

in hospital, receiving and processing, 150–153

NDC numbers, 156

Medication reconciliation, 158

Medication safety, 101–114. see also Medication errors

computerization and automation, 107

defined, 101

education and training, 107

failure mode and effects analysis, 107

multiple check systems, 107

process improvement, 107–108

self-assessment answers, 113–114

self-assessment questions, 109–113

standardization, 107

strategies, 106–107

Medication samples, handling considerations, 176

Medication therapy management (MTM), 160

Medication-use systems, deficiencies in, 106

Medium potency corticosteroids, 58

Medium-risk compounds, 82

Medrol, 48

Medroxyprogesterone, 67

Medroxyprogesterone acetate, 59

MedStation, 158

Mefoxin, 61

Megace, 67

Megestrol acetate, 67

Meglitinides, 52, 70

Mekinist, 68

Meloxicam, 50

Melphalan, 66

Memantine, 37

Memantine/donepezil, 37

Meningitis, 64

Meningococcal vaccine, 64

Menopur, 59

Menotropin, 59

Men’s health, 59–60

benign prostatic hypertrophy (BPH), agents used to treat, 60

contraceptives, 59

erectile dysfunction, drugs for, 60

fertility agents, 59

Mental blocks, 7

Meperidine, 51, 119

Mercaptopurine, 55, 66

Mesalamine, 55

Mesna, 67

Mesnex, 67

Metabolism, 141

Metabolite, 141

Metadate, 43

Metamucil, 56

Metaxalone, 50

Meter (m), 14

Meters squared (m2), 18

Metformin, 52

Methadone, 119

Methimazole, 54

Methocarbamol, 50

Methotrexate, 66

Methylcellulose, 56

Methylin, 43

Methylphenidate, 43, 119

Methylprednisolone, 48

Methylxanthines, 47

Metoclopramide, 55

Metolazone, 44

Metoprolol, 46

Metoprolol/HCTZ, 44

Metoprolol sodium succinate, 44

Metoprolol tartrate, 44

Metric system, 14, 15

Mexiletine, 46

Miacalcin, 49

Micafungin, 63

Micardis, 45

Micardis HCT, 45

Micronized progesterone, 59

Microzide, 44

Migergot, 39

Miglitol, 53

Migranal, 39

Milks, 133

Milliequivalents (mEq), 21–22

Mineral oil, 56

Minerals, 69

Minimum/maximum (par) level, 177, 178

Minipress, 60

Miotics, 57

Miralax, 56

Mirapex, 37

Mircette, 59

Mirtazapine, 40

Misleading labels, 175

Missing information, 105

Mitomycin, 66

Mitotic inhibitors, 67

Mitoxantrone, 38, 66

Mixed amphetamine salts, 43

Mixed numbers, converting, 11

MMR II, 64

Mobic, 50

Mock exams, 4

Moexipril, 45

Moexipril/HCTZ, 45

Molded tablets, 134

Molecular weight (MW), 21

Mometasone, 48, 49, 58

Monitoring errors, 102

Monoamine oxidase inhibitors (MAOIs), 40

Monoclonal antibodies, 55, 67–68, 70

Montelukast, 47

Morphine, 51, 104, 119

Mosteller formula, 17

Motrin, 50

Moxifloxacin, 57, 61

MS Contin, 51

MTX, 66

Mucinex, 49

Mucinex DM, 49

Multaq, 46

Multiple check systems, 107

Multiple-choice questions, 2

Multiple-dose vials (MDVs), 81

Multiple products, processing, 106

Multiple sclerosis agents, 38

Multiplication, 10

Multisource products, 173

Musculoskeletal system, drugs that effect, 49–51

nonsteroidal anti-inflammatory agents, 50

opioid analgesics, 51

osteoporosis agents, 49

skeletal muscle relaxants, 50

Muse, 60

Mustargen, 66

Mutamycin, 66

Mycamine, 63

Myleran, 66

N

Nabumetone, 50

Nadolol, 44

Nafcillin, 62

Nalbuphine, 51

Namenda, 37

Namzaric, 37

Naphazoline, 57

Naprelan, 50

Naprosyn, 50

Naproxen, 50

Naratriptan, 38

Nardil, 40

Nasacort, 49

Nasal route of medication administration, 138, 139

Nasonex, 49

Natalizumab, 38, 55

Nateglinide, 52

National Centers for Health Statistics, 71

National Drug Code (NDC), 91, 156, 172, 190, 192–193

National Institute for Occupational Safety and Health, 83

Nature-throid, 54

Navelbine, 67

Nebivolol, 44

Nebulizer, 136

Necitumumab, 67

Needles, 80

Nefazodone, 40

Nelfinavir (NFV), 63

Neomycin/polymyxin/dexamethasone, 57

Neomycin/polymyxin/hydrocortisone, 57

Neo-Synephrine, 49

Nervous system, drugs that effect, 36–43

ADHD, drugs for, 42–43

Alzheimer disease agents, 37

antiepileptics, 36–37

antidepressants, 40

antipsychotics, 42

anxiety disorders, drugs for, 41

bipolar disease, drugs for, 41

headaches, drugs for, 38–39

multiple sclerosis agents, 38

neuropathic pain, agents to treat, 39

Parkinson disease, 37

sedative and hypnotic medications, 42

Nesina, 53

Neupro, 37

Neurontin, 36, 39

Neuropathic pain, agents to treat, 39

Nevirapine (NVP), 62

New drug application (NDA), 121

New England Compounding Center (NECC), 179

Nexavar, 68

Nexium, 54

Next Choice, 59

Niacin, 43, 69

Niacin/lovastatin, 43

Niacin/simvastatin, 43

Niaspan, 43

Nicardipine, 46

Nicotinic acid, 43, 69

Nifedipine, 46

Nilotinib, 68

Nimodipine, 46

Nisoldipine, 46

Nitrates, 70

Nivolumab, 67

Nizatidine, 54

N-methyl-D-aspartate (NMDA) receptor antagonists, 37

Nomograms, 17

Non-antineoplastic drugs, 83, 176

Nonaqueous solutions, 133

Nonbenzodiazepine, 41

Nonbenzodiazepines, 42

Non-depolarizing neuromuscular blockers, 70

Nonformulary items, 173, 176

Non-nucleoside reverse transcriptase inhibitors (NNRTIs), 62

Nonsterile compounding, 88–93

beyond-use date, 92

categories of, 88

commonly compounded preparations, 88–89

repackaging, 89–93

Nonsteroidal anti-inflammatory drugs (NSAIDs), 50, 124, 157

Nonstimulants, 43

Norco, 51, 119

Normal saline (NS), 20

Norpace, 46

Norpace CR, 46

Norpramin, 40

Nortriptyline, 39, 40

Norvasc, 46

Norvir, 63

Novantrone, 38, 66

Novarel, 59

NovoLIN 70/30, 52

NovoLIN N, 52

NovoLIN R, 52

NovoLOG, 52

NovoLOG 70/30, 52

Noxafil, 63

NPH, 52

NPH and regular, 52

Nucleoside reverse transcriptase inhibitors (NRTIs), 62

Nucynta, 39, 51

Numbers, 9–10

Arabic, 9

as part of medication names, 105

decimal, 10–11

Roman, 9–10

Nutritional and dietary supplements, 69–71

herbals and other dietary supplements, 71

minerals and their functions in body, 69

therapeutic classes with common prefixes and suffixes, 70–71

vitamins, 69

NuvaRing, 59

Nymalize, 46

O

Objective exams, 1

computerized testing, 5

final review, 7

mental blocks, 7

preparation for, 2, 4

test-taking strategies, 5–6

trouble areas in, 6–7

OBRA 90, 116

Ocrelizumab, 38

Ocrevus, 38

Ocuflox, 57

Office of Pharmacy Affairs, 187

Office of the National Coordinator for Health Information Technology, 192

Ofloxacin, 57, 61

Oil-in-water (O/W) emulsions, 133

Ointments, 135

Olanzapine, 41, 42

Olanzapine/fluoxetine, 41

Olmesartan, 45

Olmesartan/HCTZ, 45

Olodaterol, 47

Olopatadine, 48, 57

Olux, 58

Omega-3 fatty acids, 43

Omeprazole, 54

Omission errors, 102

Omnaris, 49

Omnibus Budget Reconciliation Act, 116

Omnicef, 61

Omnicell, 158, 179

Oncaspar, 68

Ondansetron, 55

Onfi, 36

Onglyza, 53

Opana, 51

Opana ER, 51

Opdivo, 67

Ophthalmic agents, 57

Ophthalmic route of medication administration, 138, 139

Opioids, 51, 104

Oral corticosteroids, 48

Oral/inhaled corticosteroids, 48

Oral liquid systems, 91

Oral orders, 105

Oral route of administration, 137, 138

Oral solid systems, 90–91

Oramorph SR, 51

Orapred, 48

Order book, 177–178

Organization, 2

Orphenadrine, 50

Os-Cal, 49

Os-cal + D, 49

Oseni, 53

Osteoporosis agents, 49

Other body systems, drugs that affect, 57–58

ophthalmic agents, 57

psoriasis and psoriatic arthritis, biologic agents to treat, 58

topical corticosteroids, 58

Otic route of medication administration, 138, 139

Outpatient hospitals, claims processing in, 190

Outpatient PPS (OPPS), 190

Outsourcing facility, 180

Overactive bladder disorder, agents used to treat, 56

Overhead costs, 186

Over-the-counter drug review, 117

Over-the-counter (OTC) medications, 150

Oxaliplatin, 67

Oxaprozin, 50

Oxaydo, 51

Oxcarbazepine, 36, 41

Oxtellar XR, 36

Oxybutynin, 56

Oxycodone, 51, 119

OxyContin, 51, 119

OxyIR, 119

Oxymetazoline, 49

Oxymorphone, 51

P

Pacerone, 46

Package inserts, 121–122

Paclitaxel, 67

Paliperidone, 42

Palonosetron, 55

Pamelor, 39, 40

Pantoprazole, 54

Pantothenic acid, 69

Parathyroid hormone analog, 49

Parenteral medications, 75–77. see also Intravenous (IV) therapy; see also Total parenteral nutrition (TPN)

defined, 75

route of administration, 137, 138, 139

Pareto/ABC analysis, 177, 178

Parkinson disease, 37

Par level, 177, 178

Parlodel, 37

Parnate, 40

Paroxetine, 40

Particulate matter in IV therapy, 76

Pastes, 135

Pastilles, 135

Pataday, 57

Patanase, 48

Patanol, 57

Pathocil, 62

Patient assistance programs (PAPs), 187

Patient counseling, 87, 107

Patient data, integrating, 195

Patient identification numbers, 151

Patient package insert (PPI), 121, 122

Patient privacy, 122–123

Patient-specific calculations, 17

Paxil, 40

Paxil CR, 40

Payment for drugs and dispensing services, 187–189

consumers (self-pay), 187

private insurance, 187–188

public payers, 188–189

PCSK-9 inhibitors, 43

PDE5 inhibitors (phosphodiesterase inhibitors), 70

Pediatric formulations, 22

Pegaspargase, 68

Pemetrexed, 66

Penicillinase-resistant penicillins, 62

Penicillin G, 62

Penicillins, 62, 70

Penicillin VK, 62

Pentasa, 55

Pepcid, 54

Perampanel, 36

Percentages, 12

concentration expressed as, 19, 20

converting to fractions, 12

fractions converted to, 12

Percentage strength, 19

Percent volume-in-volume (v/v), 12, 19, 20

Percent weight-in-volume (w/v), 12, 19, 20

Percent weight-in-weight (w/w), 12, 19, 20

Percocet, 51

Perforomist, 47

Peri-Colace, 56

Perindopril, 45

Peristaltic pumps, 91

Personal protective equipment (PPE), 78–79, 84

Pexeva, 40

Pharmaceutical waste management, 179

Pharmacist counseling, 116, 118

Pharmacodynamics, 142

Pharmacogenomics, 142

Pharmacokinetics, 140–142

absorption, 140

distribution, 140–141

drug interactions, 142

excretion, 141–142

metabolism, 141

patient variables affecting, 142

Pharmacology review

anti-infectives, 60–64

body systems, drugs that effect, 36–58

hematologic agents, 65

nutritional and dietary supplements, 69–71

oncologic agents, 66–68

self-assessment answers, 74

self-assessment questions, 72–74

vaccines, 64

women’s and men’s health, 59–60

Pharmacy

accrediting and regulatory agencies, 159

administration of medications, 158

community pharmacies, 159–160

dietary supplements, 160

drug information questions, 160–163

home care, 160

immunizations, 160

inpatient pharmacy services, 157–158

institutional pharmacy, 158

medication management, 158

medication therapy management, 160

practice trends, 160

professional roles in, 149–150

self-assessment answers, 169

self-assessment questions, 164–169

terms and abbreviations, 150

transitions of care, 158–159

Pharmacy and Therapeutics (P&T) Committee, 158

Pharmacy benefits managers (PBMs), 159, 187–188

Pharmacy compounding, 75, 77

Pharmacy informatics, 191–192, 196, 197

defined, 191–192

knowledge, skills, and abilities, 197

specialized roles in, 196, 197

Pharmacy information system (PIS), 195

Pharmacy inventory management

compounding manufacturers, 180

counterfeit pharmaceuticals, 179

direct purchasing, 173–174

Drug Quality and Security Act, 179–180

drug wholesaler, 174

expired pharmaceuticals, disposal and return of, 180–181

formulary system, 172–173

maintaining and managing inventory, 177–179

NDC number, 172

pharmaceutical waste management, 179

prime vendor purchasing, 174

product handling considerations, 175–177

purchasing and inventory control system, 172

purchasing groups, 173

receiving process, 174–175

section 340B of the Public Health Service Act (340B), 180

self-assessment answers, 183

self-assessment questions, 181–183

specialty pharmaceuticals, procuring, 180

storing process, 175

Pharmacy law, 115–129

brand name drugs and generic drugs, 121–122

controlled substances, 118–120

drug recalls, 124–126

FDA and drug regulation in U.S., history of, 117

limited distribution drugs, 123–124

patient package inserts, 121–122

patient privacy, 122–123

pharmacist counseling, 116, 118

pharmacy technicians, 116

prescription drug information for patients, 122

risk evaluation and mitigation strategy, 123–124

self-assessment answers, 129

self-assessment questions, 126–129

state boards of pharmacy, 116

state pharmacy laws and regulations, 116

Pharmacy management systems (PMSs), 195

Pharmacy satellites, 157

Pharmacy Technician Certification Board (PTCB), 2, 5

Pharmacy technician informaticist (PTI), 192

Pharmacy technicians, laws and regulations for, 116

Pharmacy terms and abbreviations, 150

Phenelzine, 40

Phenergan, 55

Phenobarbital, 36, 119

Phenylephrine, 49, 57

Phenytoin, 36

Phillips Milk of Magnesia, 56

Phlebitis in IV therapy, 76

Phosphodiesterase inhibitors (PDE5 inhibitors), 70

Phosphorous, 69

Physical and occupational therapists, 160

Physician offices, claims processing in, 190

Phytonadione, 69

Pilocarpine, 57

Pioglitazone, 52

Pioglitazone/glimepiride, 53

Pioglitazone/metformin, 53

Piroxicam, 50

Pitavastatin, 43

Plan B, 59

Plan-Do-Study-Act (PDSA), 108

Platinum compounds, 71

Pneumococcal vaccine, 64, 160

Podophyllotoxin derivatives, 68

Poison Prevention Packaging Act, 122

Policies and procedures

admixture programs, 84–85

borrowing pharmaceuticals, 174

implementing change, 108

labeling, 106

waste disposal and spill cleanup, 84

Poliomyelitis vaccine, 64

Polycarbophil, 56

Polyethylene Glycol–PEG, 56

Portrazza, 67

Posaconazole, 63

Potassium, 69

Potassium chloride concentrated injection, 104

Potassium-sparing diuretics, 44

Potiga, 36

Pouch packaging systems, 90

Powders, 136

Practice exams

answers, 217, 230

questions, 205–216, 219–229

Practice trends, 160

Pradaxa, 65

Praluent, 43

Pramipexole, 37

Pramlintide, 53

Prandimet, 53

Prandin, 52

Pravachol, 43

Pravastatin, 43

Prazosin, 60

Precose, 53

Precursor, 118

Prednisolone, 48

Prednisone, 48

Prefixes

Greek, 14

Latin, 14

with standard measures, 14–15

Pregabalin, 36, 39

Pregnyl, 59

Prepackaging, 90

Preprinted order forms, 107

Prescription compounding, 85–88

Prescription Drug Marketing Act, 117, 181

Prescription drugs

defined, 150

forgeries, 154

in hospital, receiving and processing, 153

information for patients, 122

investigational drugs, 157

prescribing concerns, 105

prescribing errors, 102

processing, 154–156, 190–191

restricted-use medications, handling, 156–157

transferring, 156

Prescription identification (ID) card, 188

Prevacid, 54

Prezista, 62

Prilosec, 54

Primary engineering control (PEC), 77

Prime vendor purchasing, 174

Principen, 62

Prinivil, 45

Prioritizing, 3

Pristiq, 40

Private insurance, 187–188

ProAir HFA, 47

ProAir RespiClick, 47

Procainamide, 46

Procarbazine, 66

Procardia, 46

Process validation, 85

Prochlorperazine, 55

Procrastination, avoiding, 3

Prodrug, 141

Product handling considerations, 175–177

Product similarity, 175

Professional roles in pharmacy, 149–150

Progesterone and estrogen products, 59

Progesterone-only products, 59

Progesterone vaginal, 59

Project BioShield Act, 117

Proleukin, 67

Prolia, 49

Promethazine, 55

Prometrium, 59

Propafenone, 46

Propranolol, 44, 46

Propylthiouracil, 54

Proscar, 60

Prospective payment system (PPS), 186, 190

Prostaglandin analogs, 57, 71

Protease inhibitors (PIs), 62–63, 71

Proteasome inhibitor, 68

Protected health information (PHI), 123

Protective apparel. see Personal protective equipment (PPE)

Protonix, 54

Proton pump inhibitors, 54, 71

Protriptyline, 40

Proventil HFA, 47

Provera, 67

Prozac, 39, 40

Pseudoephedrine, 49, 120

Psoriasis, agents to treat, 58

Psoriatic arthritis, agents to treat, 58

Psyllium, 56

PTU, 54

Public Health Service Act, 180

Public payers, 188–189

Medicaid, 189

Medicare, 188–189

other, 189

Pulmicort, 48

Punch cards, 90

Purchase order (PO), 173

Purchasing and inventory control system, 172

Purified protein derivative (PPD), 139

Purinethol, 55

Purixan, 55, 66

Pyridoxine, 69

Pyrogens, 76

Pyxis, 158

Pyxis Medstation, 179

Q

Quality assurance

continuous quality improvement, 125

drug recalls, 125, 126

IV admixture programs, 85

pharmacy technician’s role in, 150

quality improvement, 126

record keeping, 92

Quality control

checkpoints, 93

compounding, 87

drug recalls, 125, 126

end-product testing, 93

maintenance of equipment, 92–93

personnel training and competency, 92

repackaging, 92–93

Quality improvement (QI), 126

Quarter normal saline (1/4 NS), 20

Quazepam, 42

Question charts, 3–4

Questran, 43

Quetiapine, 41, 42

Quinapril, 45

Quinapril/HCTZ, 45

Quinidine, 46

QVAR, 48

R

Rabeprazole, 54

Radiopharmaceuticals, 177

Raloxifene, 49

Raltegravir (RAL), 63

Ramelteon, 42

Ramipril, 45

Ramucirumab, 67

Ranitidine, 54

Rapaflo, 60

Rapid-acting insulins, 52

Rasagiline, 37

Ratio and proportion method, 13–14

Ratio strength, concentration expressed as, 20–21

Razadyne, 37

React, 59

Rebif, 38

Receiving process, 174–175

Reclast, 49

Reclipsen, 59

Reconstitute a vial, 81

Record-keeping systems, for repackaged medications, 92

Rectal route of medication administration, 138, 139

Registered dietitians, 160

Reglan, 55

Regular, 52

Reimbursement basics, 186–187

Rejection code, 188

Relpax, 38

Remeron, 40

Remicade, 55, 58

Remifentanil, 51

Repackaging, 89–91

advantages and disadvantages of, 89

beyond-use dating, 92

containers and repackaging materials, 90

extemporaneous versus batch repacking, 90

labeling, 92

quality control, 92–93

record keeping, 92

unit-dose packaging, 89

unit-of-use packaging, 89–90

Repackaging equipment, 90–91

oral liquid systems, 91

oral solid systems, 90–91

Repaglinide, 52

Repaglinide/metformin, 53

Repatha, 43

Reproductive risk HDs, 176

Requip, 37

Rescriptor, 62

Resource Conservation and Recovery Act (RCRA) regulations, 177

Respiratory system, drugs that effect, 47–49

antihistamines, 48

asthma and COPD, agents to treat, 47

cough and cold agents, 49

oral/inhaled corticosteroids, 48

Respiratory therapists, 160

Restasis, 57

Restoril, 42

Restricted-use medications, 156–157

Retail practice, 194–195

electronic prescribing, 194–195

integrating patient data, 195

pharmacy management systems, 195

telepharmacy, 195

Retinoids, 68

Retinol, 69

Retrospective payment model, 186

Retrovir, 62

Reyataz, 62

Rhinocort, 49

Riboflavin, 69

Rilpivirine (RPV), 62

Riomet, 52

Risedronate, 49

Risedronate/calcium, 49

Risk evaluation and mitigation strategy (REMS), 123–124, 156–157

Risperdal, 41, 42

Risperdal Consta, 42

Risperidone, 41, 42

Ritalin, 43, 119

Ritonavir (RTV), 63

Rituxan, 67

Rituximab, 67

Rivaroxaban, 65

Rivastigmine, 37

Rizatriptan, 38

Robaxin, 50

Robitussin, 49

Robitussin DM, 49

Robotics, 193

Rocephin, 61

Roman numerals, 9–10

Root cause analysis (RCA), 108

Ropinirole, 37

Rosiglitazone, 52

Rosiglitazone/glimepiride, 53

Rosiglitazone/metformin, 53

Rosuvastatin, 43

Rotarix, 64

RotaTeq, 64

Rotavirus gastroenteritis, 64

Rotavirus vaccine, 64

Rotigotine, 37

Routes of administration, 137–139

buccal, 137, 138

enteral, 137, 138

oral, 137, 138

parenteral, 137, 138, 139

self-assessment answers, 147

self-assessment questions, 144–146

subgingival, 137, 138

sublingual, 137, 138

topical, 138, 139

transmucosal, 137, 138

Rowasa, 55

Roxanol, 51

Roxicet, 51

Rozerem, 42

Ruxolitinib, 68

Rx Only, 150

Rythmol, 46

S

Safety Data Sheet, 87

St. John’s wort, 71

Saline laxatives, 56

Salmeterol, 47

Salmeterol/fluticasone, 47

Sanctura, 56

Sanctura XR, 56

Sancuso, 55

Saquinavir (SQV), 63

Sarafem, 40

Savaysa, 65

Saxagliptin, 53

Saxagliptin/metformin, 53

Schedules for controlled substances, 118–119

Scopolamine, 55

Seasonique, 59

Secondary engineering controls (SECs), 78

Second-generation agents, 38, 60–61

Secretagogues, 52

Section 340B of the Public Health Service Act (340B), 180, 187

Secukinumab, 58

Sedative medications, 42, 119

Selective estrogen receptor modulators (SERMs), 49, 68

Selective norepinephrine reuptake inhibitors (SNRIs), 40

Selective serotonin reuptake inhibitors (SSRIs), 40

Selegiline, 37

Semi-automated systems, 91

Semisolid medication dosage forms, 135–137

aerosols, 136

creams, 135

extended-release dosage forms, 135–136

granules, 136

implants, 137

inhalants, 136

liniments, 136–137

ointments, 135

pastes, 135

powders, 136

transdermal patches, 137

Senna, 56

Senna/docusate sodium, 56

Senokot, 56

Senokot-S, 56

Serevent, 47

Seroquel, 41, 42

Seroquel XR, 41, 42

Sertraline, 40

Service units, 190

Serzone, 40

Shaft of needle, 80

Sherley Amendment, 117

Shingles vaccine, 64, 160

Short-acting bronchodilators (SABAs), 47

Short-acting insulins, 52

Short infusion, 139

Sildenafil, 60

Siliq, 58

Silodosin, 60

Simbrinza, 57

Simcor, 43

Simponi, 55, 58

Simvastatin, 43

Sinemet, 37

Sinemet CR, 37

Sinequan, 40

Single-dose vials, 81

Singulair, 47

Sitagliptin, 53

Sitagliptin/metformin, 53

Site of action, 140–141

Six Sigma, 126

Skelaxin, 50

Skeletal muscle relaxants, 50

Skilled nursing facility, claims processing in, 190

Smart pumps, 82

Social Security Act, 180

Social workers, 160

Sodium, 69

Sodium-glucose cotransporter 2 inhibitors (SGLT-2) inhibitors, 53

Soft gelatin capsules, 135

Sole-source branded products, 173

Solid medication dosage forms, 134–135

caplets, 134, 135

capsules, 134, 135

lozenges, 134, 135

semisolids, 134, 135–137

suppositories, 134, 135

tablets, 134–135

Solifenacin, 56

Soliqua, 52

Soltamox, 68

Solu-Medrol, 48

Solutions, 88–89, 132–133

Soma, 50

Sonata, 42

Sorafenib, 68

Sotalol, 44, 46

Sotret, 123, 157

Soy, 71

Specialized applications, 193

Specialty pharmaceuticals, procuring, 180

Specialty pharmacy practice, 180

Spill cleanup, 84

Spill kits, 84

Spirits, 133

Spiriva Handihaler, 47

Spiriva Respimat, 47

Spironolactone, 44

Spironolactone/HCTZ, 44

Sporanox, 63

Sprycel, 68

Square meter surface area, 17

SSKI, 54

Stability, 81, 86

Stadol, 51

Stalevo, 37

Standardization, 107

Standard measures, 14–15

Starlix, 52

STAR safety tool, 106

STAT, 151

State boards of pharmacy, 116

State pharmacy laws and regulations, 116

State prescription drug monitoring programs, 120

Stavudine (d4T), 62

Stelara, 55, 58

Sterile compounding, 75–88

admixture programs, 84–85

area, 78–79

aseptic technique, 76

attire, 87

beyond-use date, 86

categories of compounds, 81–82

compounding record, 87

engineering controls, 77

equipment and procedures, 87–88

facilities, 86

hazardous sterile compounding, 83–84

ingredients for, 86

IV administration, types of, 75–76

IV therapy risks, 76

labeling, 82

manufacturing differentiated from, 85

master formulation record, 87

parenteral medications, 75

patient counseling, 87

pharmacy, 75, 77

prescription, 85–88

quality control, 87

regulations, 76–77

Safety Data Sheet, 87

stability, 81, 86

sterile compounding area, 78–79

supplies, 79–82

technique, 79

total parenteral nutrition solutions, 82–83

USP-NF Chapter <795>, 86–87

Stimulant laxatives, 56

Stimulants, 42–43

Stiolto Respimat, 47

Stock rotation, 175

Stock solutions, dilutions made from, 21–22

Stool softeners, 56

Storing hazardous drugs, 84

Storing process, 175

Strattera, 43

Striverdi, 47

Subcutaneous (sub-Q) route of medication administration, 139

Subgingival route of administration, 137, 138

Sublimaze, 51

Sublingual route of administration, 137, 138

Sublingual tablets, 134

Suboxone, 51

Substitutions, 121

Subtraction, 10

Subutex, 51

Sudafed, 49

Sudafed PE, 49

Sufenta, 51

Sufentanil, 51

Sular, 46

Sulfacetamide, 57

Sulfasalazine, 55

Sulfonamides, 71

Sulfonylureas, 52

Sulfur, 69

Sulindac, 50

Sumatriptan, 38

Sumatriptan and naproxen, 39

Sunitinib, 68

Suppositories, 89, 134, 135

Suprax, 61

Surfak, 56

Suspensions, 88–89, 132, 133

Sustiva, 62

Sutent, 68

Symbicort, 47

Symbyax, 41

Symlin, 53

Symmetrel, 37

Sympathomimetics, 57

Synjardy, 53

Synthroid, 54

Syringes, 79–80

T

Tablets, 134–135

Tabloid, 66

Tadalafil, 60

Tafinlar, 68

Tafluprost, 57

Tagamet HB, 54

TALL man lettering, 105

Taltz, 58

Tamoxifen, 68

Tamper-resistant packaging regulations, 117

Tamsulosin, 60

Tanzeum, 53

Tapazole, 54

Tapentadol, 39, 51

Tarceva, 68

Targretin, 68

Tarka, 45

Tasigna, 68

Tasmar, 37

Tavist, 48

Taxanes, 71

Taxotere, 67

Tecfidera, 38

Tech-Check-Tech system, 107

Teflaro, 61

Tegretol, 36, 39, 41

Tegretol XR, 36

Tekturna HCT, 44

Telepharmacy, 195

Telephone orders, 105

Telmisartan, 45

Telmisartan/HCTZ, 45

Temazepam, 42

Temovate, 58

Temperature conversion, 16

Tenecteplase, 65

Teniposide, 68

Tenofovir (TFV), 62

Tenoretic, 44

Tenormin, 44, 46

Terazosin, 60

Teriflunomide, 38

Teriparatide, 49

Terminology, key, 191–193

Terms, definition of, 4

Test anxieties, 7–8

Test-taking strategies, 5–6

Tetanus/diphtheria/pertussis vaccine, 64

Tetanus/diphtheria vaccine, 64

Tetracycline, 71

Tetrahydrozoline, 57

Thalidomide, 123, 157

Thalomid, 123, 157

Theo-24, 47

Theochron, 47

Theophylline, 47

Therapeutic classes with common prefixes and suffixes, 70–71

Thiamine, 69

Thiazide diuretics, 44, 71

Thiazolidinediones, 52, 71

Thioguanine, 66

Thioridazine, 42

Thiothixene, 42

Third-generation agents, 61

Third-party payer, 186, 187

Third-party prescriptions, processing, 188

3-way repeat back patient safety tool, 105

340B drug-pricing program, 180, 187

Thrombolytic drugs, 65, 71

Thyroid agents, 54

Thyroid USP, 54

Thyrolar, 54

Tiagabine, 36

Tiazac, 46

Tigan, 55

Tikosyn, 46, 123, 157

Time allocation, 3

Time conversion, 17

Time management, 2

Timolol, 57

Timoptic, 57

Timoptic-XE, 57

Tinctures, 133

Tiotropium, 47

Tiotropium/olodaterol, 47

Tipranavir (TPV), 63

Tirosint, 54

Tivicay, 63

Tizanidine, 50

TNF-α inhibitors immunomodulators, 70

TNKase, 65

Tobradex, 57

Tobramycin, 57

Tobramycin/dexamethasone, 57

Tobrex, 57

Tocopherol, 69

To do lists, 2–3

Tofranil, 40

Tofranil-PM, 40

Tolcapone, 37

Tolterodine, 56

Topamax, 36, 39

Topical agents

corticosteroids, 58

decongestants, 49

for neuropathic pain, 39

Topical route of administration, 138, 139

Topicort, 58

Topiramate, 36, 39

Topoisomerase inhibitors, 68, 71

Toposar, 68

Topotecan, 68

Toprol XL, 44, 46

Toremifene, 68

Torsemide, 44

Total parenteral nutrition (TPN), 82–83

automated TPN compounding, 82–83

components of TPN solutions, 82

Total Quality Management (TQM), 126

Toujeo, 52

Toviaz, 56

Tradjenta, 53

Trailing zero, 11, 103, 107

Training. see Education and training

Tramadol, 51

Trametinib, 68

Trandate, 44

Trandolapril, 45

Trandolapril/verapamil, 45

Transdermal patches, 137

Trans-Derm Scop, 55

Transferring prescriptions, 156

Transitions of care, 158–159

errors, 103

Transmucosal immediate-release fentanyl (TIRF) products, 157

Transmucosal route of administration, 137, 138

Transporting hazardous drugs, 84

Tranylcypromine, 40

Trastuzumab, 68

Travatan, 57

Travel vaccines, 160

Travoprost, 57

Trazodone, 40

Tremfya, 58

Tresiba, 52

Tresiba U-200, 52

Trexall, 66

Treximet, 39

Triamcinolone, 49, 58

Triaminic Cold PE, 49

Triamterene, 44

Triamterene/HCTZ, 44

Triazolam, 42

Tribenzor, 46

TRICARE, 189

Tricor, 43

Tricyclic antidepressants, 40

Trifluoperazine, 42

Trifluridine, 57

Triglide, 43

Trihexyphenidyl, 37

Trileptal, 36, 41

Trilipix, 43

Trimethobenzamide, 55

Trintellix, 40

Triptans, 38–39, 70

Trivora, 59

Troches, 89, 135

Trospium, 56

Trulicity, 53

Trusopt, 57

Tudorza, 47

Tums, 49

24-hour supply of medication, calculating, 19

Tykerb, 68

Tylenol #3, 51, 119

Tysabri, 38, 55

U

Ultiva, 51

Ultracet, 51

Ultram, 51

Umeclidinium, 47

Umeclidinium/vilanterol, 47

Unasyn, 62

Unauthorized drug errors, 102

Unfractionated heparin, 65

Unipen, 62

Unique medical record number, 151

Uniretic, 45

Unit-dose packaging, 89

United States Pharmacopeia (USP), 76–77

Unithroid, 54

Unit-of-use packaging, 89–90

Units of measure, 14–15

Units of service, 190

Universal product code (UPC), 192

Unknown ratio, 13–14

Urinary system, drugs that effect, 56

Urofollitropin, 59

Uroxatral, 60

USP-NF Chapter <795>, 86–87

active and inactive ingredients, 86

compounding attire and Safety Data Sheet, 87

compounding facilities, 86

compounding record, 87

labeling, 87

master formulation record, 87

patient counseling, 87

quality control, 87

sources of ingredients, 86

stability and beyond-use date, 86

USP-NF Chapter <800>, 84, 176

Ustekinumab, 55, 58

Usual and customary price, 187

V

Vaccines, 64

Valchlor, 66

Valium, 36, 41, 50, 119

Valproate sodium, 36

Valproic acid, 36

Valsartan, 45

Valsartan/HCTZ, 45

Valsartan/Sacubitril, 45

Vanos, 58

Vardenafil, 60

Varenicline, 124

Varicella vaccine, 64

Varivax, 64

Vaseretic, 45

Vasoconstrictors, 57

Vasotec, 45

Vedolizumab, 55

Velcade, 68

Venlafaxine, 39, 40

Ventolin HFA, 47

Verapamil, 46

Verelan, 46

Versacloz, 42

Vertical LAFWs, 77, 83

Very high potency corticosteroids, 58

VESIcare, 56

Vfend, 63

Viactiv, 49

Viactiv + D, 49

Viagra, 60

Vials, 80–81

Vicodin, 51, 119

Vicoprofen, 51

Victoza, 53

Videx, 62

Vigamox, 57

Viibryd, 40

Vilanterol/fluticasone, 47

Vilazodone, 40

Vimpat, 36

Vinblastine, 67

Vinca alkaloids, 71

Vincasar, 67

Vincristine, 67

Vinorelbine, 67

Viracept, 63

Viramune, 62

Viread, 62

Viroptic, 57

Viscous aqueous solutions, 132–133

Visine, 57

Vitality supplements, 71

Vitamin A, 69

Vitamin B1, 69

Vitamin B2, 69

Vitamin B3, 69

Vitamin B5, 69

Vitamin B6, 69

Vitamin B12, 69

Vitamin C, 69

Vitamin D, 69

Vitamin E, 69

Vitamin K, 69

Vitamin K1 inhibitors, 65

Vitamins, 69

Vitekta, 63

Vivactil, 40

Voltaren, 50

Volume, 14, 16

Volume of distribution, 141

Volumetric pumps, 91

Voriconazole, 63

Vortioxetine, 40

Vytorin, 43

Vyvanse, 42

W

Warfarin sodium, 65

Waste disposal, 84

Water-in-oil (W/O) emulsions, 133

Weight

calculating dose based on, 18

metric prefixes for, 14–15

percentage strength measured in, 19

Weight loss supplements, 71

Welchol, 43

Wellbutrin, 39, 40

Wellbutrin SR, 40

Wellbutrin XL, 40

Wholesale acquisition cost (WAC), 186

Wholesaler, 174

Women’s health

CAM supplements in, 59

contraceptives, 59

fertility agents, 59

Work environment, medication errors and, 106

Workflow software, IV, 193

Work habits, 2–3

distractors, eliminating, 3

to do lists, 2–3

organization, 2

prioritizing, 3

procrastination, avoiding, 3

time allocation, 3

Wrong administration technique errors, 102

Wrong dosage form errors, 102

Wrong drug preparation errors, 102

Wrong time error, 102

X

Xalatan, 57

Xanax, 41

Xarelto, 65

Xeloda, 66

Xigduo, 53

Xopenex, 47

Xopenex HFA, 47

Xulane, 59

Xultophy, 52

Xylocaine, 46

Xyzal, 48

Z

Zaditor, 57

Zafirlukast, 47

Zaleplon, 42

Zanaflex, 50

Zantac, 54

Zaroxolyn, 44

Zelapar ODT, 37

Zerit, 62

Zero Defects, 126

Zestoretic, 45

Zestril, 45

Zetia, 43

Zevalin, 67

Ziac, 44

Ziagen, 62

Zidovudine (AZT, ZDV), 62

Zileutin, 47

Zinacef, 61

Zinbryta, 38

Zioptan, 57

Ziprasidone, 41, 42

Zirgan, 57

Zithromax, 61

Zocor, 43

Zofran, 55

Zohydro, 51

Zoledronic acid, 49

Zolmitriptan, 38

Zoloft, 40

Zolpidem, 42

Zolpmist, 42

Zomig, 38

Zonegran, 36

Zonisamide, 36

Zostavax, 64

Zostrix, 39

Zuplenz, 55

Zydelig, 68

Zyflo, 47

Zyflo CR, 47

Zymaxid, 57

Zyprexa, 41, 42

Zyprexa Relprevv, 42

Zyprexa Zydis, 42

Zyrtec, 48

If the inline PDF is not rendering correctly, you can download the PDF file here.